If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Succession Planning Update

16 Jul 2015 17:20

RNS Number : 3057T
BlueCrest AllBlue Fund Ltd
16 July 2015
 



16 July 2015

 

BLUECREST ALLBLUE FUND LIMITED (THE 'COMPANY')

 

SUCCESSION PLANNING UPDATE

 

In the Annual Financial Report for the year ended 31 December 2014 (the "AFR"), the Company advised that it was scheduled to consider the tenure of directors once any director has been appointed to the Board for a continuous period of nine years and that this would occur in 2015 for Messrs Crowder, Meader and Le Prevost, with the intention that in order to achieve orderly succession and to retain 'corporate memory', it is the intention of the Board that one of each of the above three directors should step aside in each calendar year starting in 2015. Notwithstanding their nine years service the Company considers that Richard, Paul and John remain able to act independently.

 

Further to this disclosure, investors may have noted that the Company has appointed Miss Sarita Keen as an independent non executive director effective 3 June 2015. Sarita brings an in depth knowledge of Guernsey fund administration and has already made a valuable contribution to the Board.

 

In line with the succession plan disclosed in the AFR it is the intention of the Company that Sarita takes on the duties of John Le Prevost in due course and that John Le Prevost will be the first of the three directors named above to retire. The Company anticipates that this will occur before the end of the year.

 

The Board believes that one of the distinctions of an investment company such as BCAB is that there are no executives or investment managers to carry out duties such as monitoring the valuation process, cash pot policy and conversion mechanism. For the Company the failure of any of these mechanisms is a significant risk and many of these procedures (for instance inter share class conversions) take place over a period of some 6-8 weeks, and so the Board considers that a 5 month handover period is not excessively long. However, five months is the anticipated maximum in this case.

 

The Board is also actively seeking a replacement for Richard Crowder, as chairman. Next year the Board will review the position of Paul Meader, in line with the succession plan.

 

For further information about this announcement contact:

 

JTC (Guernsey) Limited

Secretary

Tel: +44 (0) 1481 702 400

E&OE - in transmission

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRQQLFFEDFBBBK
Date   Source Headline
1st Jun 20174:56 pmRNSHolding(s) in Company
1st Jun 20174:32 pmRNSHolding(s) in Company
1st Jun 20171:32 pmRNSHolding(s) in Company
31st May 201710:50 amRNSNet Asset Value(s)
23rd May 201711:50 amRNSNet Asset Value(s)
23rd May 20179:51 amRNSEstimated Creditor Interests
23rd May 20179:48 amRNSNet Asset Value(s)
16th May 201711:12 amRNSNet Asset Value(s)
10th May 20174:40 pmRNSConfirmation of AllBlue Proceeds Received
9th May 201711:07 amRNSNet Asset Value(s)
3rd May 201710:46 amRNSNet Asset Value(s)
2nd May 201710:05 amRNSInvestor Communication from AllBlue Limited
2nd May 20179:57 amRNSTender Offer and Buyback Programme
28th Apr 201712:34 pmRNSEstimated Creditor Interests
28th Apr 201712:25 pmRNSNet Asset Value(s)
25th Apr 201711:17 amRNSNet Asset Value(s)
20th Apr 20177:00 amRNSHolding(s) in Company
19th Apr 201711:29 amRNSNet Asset Value(s)
11th Apr 201711:58 amRNSNet Asset Value(s)
5th Apr 20175:18 pmRNSHolding(s) in Company
5th Apr 201710:01 amRNSNet Asset Value(s)
4th Apr 20175:22 pmRNSHolding(s) in Company
3rd Apr 201711:51 amRNSAnnual Financial Report and Notice of AGM
3rd Apr 201711:37 amRNSDirector Declaration
30th Mar 20173:53 pmRNSCash Received Update
28th Mar 201711:34 amRNSNet Asset Value(s)
24th Mar 201712:26 pmRNSEstimated Creditor Interests
24th Mar 201711:39 amRNSNet Asset Value(s)
21st Mar 201710:25 amRNSNet Asset Value(s)
14th Mar 201711:11 amRNSNet Asset Value(s)
10th Mar 20175:34 pmRNSTransaction in Own Shares
10th Mar 20172:42 pmRNSAppointment of Corporate Broker
7th Mar 201712:11 pmRNSNet Asset Value(s)
3rd Mar 201712:28 pmRNSNet Asset Value(s)
3rd Mar 201712:17 pmRNSHolding(s) in Company
3rd Mar 201712:16 pmRNSHolding(s) in Company
3rd Mar 201712:15 pmRNSHolding(s) in Company
2nd Mar 20172:00 pmRNSEstimated Creditor Interests
2nd Mar 20171:59 pmRNSNet Asset Value(s)
28th Feb 201712:34 pmRNSNet Asset Value(s)
22nd Feb 20175:11 pmRNSHolding(s) in Company
22nd Feb 201712:31 pmRNSNet Asset Value(s)
17th Feb 20175:44 pmRNSTransaction in Own Shares
15th Feb 20174:04 pmRNSConfirmation of Tender Offer Payments
14th Feb 20171:05 pmRNSNet Asset Value(s)
10th Feb 20175:28 pmRNSTransaction in Own Shares
9th Feb 20176:15 pmRNSCreditor Interest Update - clarification
9th Feb 20173:49 pmRNSEstimated Creditor Interests
8th Feb 20171:53 pmRNSHolding(s) in Company
7th Feb 20174:09 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.